MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study
Journal Article

Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study

2025
Request Book From Autostore and Choose the Collection Method
Overview
Delirium is a common neuropsychiatric complication in patients with advanced cancer. Central nervous system (CNS)-active medications are established risk factors for delirium; however, these patients often require polypharmacy for symptom management, resulting in a high medication burden and increased risk of drug-drug interactions (DDIs). The impact of CNS medication burden and DDIs on delirium remains unclear. This multicenter, prospective observational study examined the association between CNS medication burden, measured using the CNS standardized daily dose (SDD), DDIs, and delirium incidence, duration, and mortality in hospitalized patients with advanced cancer. Among 190 patients, 20% developed delirium. CNS SDD was associated with delirium risk (adjusted OR [aOR]: 1.04, 95% CI: 1.0004–1.08). In categorical analyses, patients with a CNS SDD ≥ 10 had a significantly higher risk of delirium (aOR: 4.29, 95% CI: 1.33–15.47). Potential DDIs increasing exposure to delirium-risk medications had an aOR of 4.14 (95% CI: 0.96–17.41). Although neither CNS SDD nor DDIs affected delirium duration, opioid burden was associated with increased mortality. CNS medication burden and DDIs may be important factors for delirium and clinical outcomes. These findings underscore the need for medication optimization and proactive DDI monitoring to reduce the risk of delirium and improve patient outcomes.